Zobrazeno 1 - 10
of 88
pro vyhledávání: '"R S, Berkowitz"'
Autor:
D. C. Ihde, A. M. Fremgen, J. M. Cain, D. Lowy, M. R. Henry, A. H. Epstein, B. L. Andersen, J. R. Lunney, P. W. Grigsby, D. K. Ash, J. Ruffin, M. H N Tattersall, M. F. Mitchell, H. W. Lawson, Frederick Stehman, R. C. Park, C. McNeil, P. J. Hitchcock, B. S. Kramer, J. F. Magrina, J. M. Elliott, M. A. Penalver, W J Jr Spanos, A. S. Lichter, R. S. Berkowitz, R. M. Lanciano, P. E. Saigo, J. H. Ferguson, I. Gage, M. A. Steller, C. Nichols, P. S. Braly, Carol L. Brown, C. P. Hunter, R. L. Sweet, J. L. Bader, M. E. Randall, K. D. Hatch, W. H. Hall, V. W. Pinn, J. Overgaard, G L Sr Eddy, A. H. Rusell, D. Kapp, G. A. Omura, A. E. Howes, M. Morris, D. G. Petereit, J. A. Benda, J. S. Hutchison, P. J. Eifel, A. F. Saftlas, R. Herrero, H. M. Keys, S. Scherr, N. Munoz, G. M. Thomas
Publikováno v:
Gynecologic Oncology. 66:351-361
Autor:
R S, Berkowitz, D P, Goldstein
Publikováno v:
New England Journal of Medicine. 335:1740-1748
Publikováno v:
IEEE International Conference on Radar.
The application of a short-pulse, high-angular-resolution array focused in the near field for detection and imaging of shallow subsurface objects is discussed. An experimental system based on a forward-looking bistatic radar configuration with a digi
Autor:
B H, Ortiz, M, Ailawadi, C, Colitti, M G, Muto, M, Deavers, E G, Silva, R S, Berkowitz, S C, Mok, D M, Gershenson
Publikováno v:
Cancer research. 61(19)
The role of serous borderline ovarian tumors (BOTs) in the pathogenesis of serous ovarian carcinomas is unclear. Some authors have compared mutations in serous BOTs to those in serous ovarian carcinomas, but the data on two common oncogenes, p53 and
Autor:
R T, Penson, J G, Supko, M V, Seiden, A F, Fuller, R S, Berkowitz, A, Goodman, S M, Campos, K M, MacNeill, S, Cook, U A, Matulonis
Publikováno v:
Cancer. 92(5)
Topotecan and paclitaxel are schedule dependent chemotherapeutic agents with activity against ovarian carcinoma. A Phase I-II study in which both drugs were administered concurrently by 96-hour, continuous, intravenous infusion was performed to deter
Publikováno v:
Cancer research. 61(10)
Investigation of genetic changes in tumors by loss of heterozygosity is a powerful technique for identifying chromosomal regions that may contain tumor suppressor genes. In this study, we determined allelic loss on chromosomes 5 and 6 in 29 primary e
Publikováno v:
Seminars in oncology. 27(6)
Patients with gestational trophoblastic disease (GTD) can usually achieve complete sustained remission while retaining their fertility even in the presence of wide-spread metastasis. Following complete and partial mole, our patients had 1,239 and 205
Publikováno v:
Ultrasound in obstetricsgynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 16(2)
Complete hydatidiform moles are now being diagnosed earlier in gestation, thus the clinical presentation and pathologic findings of complete molar pregnancy have changed. We studied the sonographic appearance of first trimester moles and the ability
Autor:
R S, Berkowitz
Publikováno v:
The Journal of reproductive medicine. 45(9)
Autor:
J O, Schorge, M G, Muto, S J, Lee, L W, Huang, W R, Welch, D A, Bell, E Z, Keung, R S, Berkowitz, S C, Mok
Publikováno v:
Cancer research. 60(5)
Papillary serous carcinoma of the peritoneum (PSCP) is believed to develop de novo from the peritoneal lining of the pelvis and abdomen. Although it is histologically indistinguishable from serous ovarian carcinoma, PSCP exhibits minimal or absent ov